383 related articles for article (PubMed ID: 15734787)
1. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
[TBL] [Abstract][Full Text] [Related]
2. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.
Ferguson HE; Kulkarni A; Lehmann GM; Garcia-Bates TM; Thatcher TH; Huxlin KR; Phipps RP; Sime PJ
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):722-30. PubMed ID: 19286977
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma ligands induce heme oxygenase-1 in lung fibroblasts by a PPARgamma-independent, glutathione-dependent mechanism.
Ferguson HE; Thatcher TH; Olsen KC; Garcia-Bates TM; Baglole CJ; Kottmann RM; Strong ER; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L912-9. PubMed ID: 19734319
[TBL] [Abstract][Full Text] [Related]
5. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.
Kuriyan AE; Lehmann GM; Kulkarni AA; Woeller CF; Feldon SE; Hindman HB; Sime PJ; Huxlin KR; Phipps RP
Exp Eye Res; 2012 Jan; 94(1):136-45. PubMed ID: 22178289
[TBL] [Abstract][Full Text] [Related]
6. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Nuwormegbe SA; Sohn JH; Kim SW
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.
Jeon KI; Kulkarni A; Woeller CF; Phipps RP; Sime PJ; Hindman HB; Huxlin KR
Am J Pathol; 2014 May; 184(5):1429-45. PubMed ID: 24650561
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
11. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
Hao GH; Niu XL; Gao DF; Wei J; Wang NP
Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
[TBL] [Abstract][Full Text] [Related]
12. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.
Deng YL; Xiong XZ; Cheng NS
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):467-78. PubMed ID: 23060391
[TBL] [Abstract][Full Text] [Related]
13. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production.
Pan HW; Xu JT; Chen JS
Mol Biol Rep; 2011 Oct; 38(7):4501-8. PubMed ID: 21127991
[TBL] [Abstract][Full Text] [Related]
15. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Wang WM; Liu F; Chen N
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.
Wang W; Liu F; Chen N
Mediators Inflamm; 2007; 2007():62641. PubMed ID: 18274641
[TBL] [Abstract][Full Text] [Related]
17. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
18. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
Milam JE; Keshamouni VG; Phan SH; Hu B; Gangireddy SR; Hogaboam CM; Standiford TJ; Thannickal VJ; Reddy RC
Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L891-901. PubMed ID: 18162602
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
